APA (7th ed.) Citation

Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Hegg, R., . . . Cortés, J. (2013). Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA). Annals of oncology, 24(9), . https://doi.org/10.1093/annonc/mdt182

Chicago Style (17th ed.) Citation

Schneeweiss, Andreas, et al. "Pertuzumab Plus Trastuzumab in Combination with Standard Neoadjuvant Anthracycline-containing and Anthracycline-free Chemotherapy Regimens in Patients with HER2-positive Early Breast Cancer: A Randomized Phase II Cardiac Safety Study (TRYPHAENA)." Annals of Oncology 24, no. 9 (2013). https://doi.org/10.1093/annonc/mdt182.

MLA (9th ed.) Citation

Schneeweiss, Andreas, et al. "Pertuzumab Plus Trastuzumab in Combination with Standard Neoadjuvant Anthracycline-containing and Anthracycline-free Chemotherapy Regimens in Patients with HER2-positive Early Breast Cancer: A Randomized Phase II Cardiac Safety Study (TRYPHAENA)." Annals of Oncology, vol. 24, no. 9, 2013, https://doi.org/10.1093/annonc/mdt182.